33.81
price down icon2.54%   -0.88
after-market 시간 외 거래: 33.78 -0.03 -0.09%
loading
전일 마감가:
$34.69
열려 있는:
$32.4
하루 거래량:
434.26K
Relative Volume:
0.50
시가총액:
$237.32M
수익:
-
순이익/손실:
$-112.46M
주가수익비율:
-20.62
EPS:
-1.64
순현금흐름:
$-99.89M
1주 성능:
+11.22%
1개월 성능:
-17.94%
6개월 성능:
+99.52%
1년 성능:
+122.43%
1일 변동 폭
Value
$31.84
$34.30
1주일 범위
Value
$25.40
$36.69
52주 변동 폭
Value
$2.622
$65.80

보 바이오파마 Stock (VOR) Company Profile

Name
명칭
Vor Biopharma Inc
Name
전화
617-655-6580
Name
주소
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Name
직원
168
Name
트위터
Name
다음 수익 날짜
2024-11-05
Name
최신 SEC 제출 서류
Name
VOR's Discussions on Twitter

VOR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VOR
Vor Biopharma Inc
33.81 237.32M 0 -112.46M -99.89M -1.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.87 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.58 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.51 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
711.09 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
328.71 36.23B 3.81B -644.79M -669.77M -6.24

보 바이오파마 Stock (VOR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-30 업그레이드 H.C. Wainwright Neutral → Buy
2022-07-26 개시 Wedbush Outperform
2022-04-27 개시 Goldman Neutral
2021-12-17 개시 H.C. Wainwright Buy
2021-12-03 개시 Robert W. Baird Outperform
2021-12-02 개시 Oppenheimer Outperform
2021-10-19 개시 JMP Securities Mkt Outperform
2021-03-25 개시 B. Riley Securities Buy
2021-03-03 개시 Barclays Overweight
2021-03-03 개시 Evercore ISI Outperform
2021-03-02 개시 Goldman Sell
2021-03-02 개시 Stifel Buy
모두보기

보 바이오파마 주식(VOR)의 최신 뉴스

pulisher
11:48 AM

Vor Biopharma: Transformed Company Is A High Risk Buy On Autoimmune Disease Promise - Seeking Alpha

11:48 AM
pulisher
10:40 AM

Vor Biopharma Shares Slide Following Warrant Registration Filing - MSN

10:40 AM
pulisher
10:17 AM

Vor Biopharma stock drops after filing to register warrant shares By Investing.com - Investing.com Nigeria

10:17 AM
pulisher
09:26 AM

Vor Biopharma stock drops after filing to register warrant shares - Investing.com

09:26 AM
pulisher
03:26 AM

Stifel upgrades Vor Biopharma stock to Buy on telitacicept prospects By Investing.com - Investing.com South Africa

03:26 AM
pulisher
Sep 24, 2025

Vor Biopharma (VOR) Registers 51M Shares for Resale, Warrants in Focus - GuruFocus

Sep 24, 2025
pulisher
Sep 24, 2025

Vor Biopharma files for offering of up to 51 million common shares by the selling stockholdersSEC filing - MarketScreener

Sep 24, 2025
pulisher
Sep 24, 2025

Vor Biopharma (VOR) files for 51M share offering by selling stockholders - StreetInsider

Sep 24, 2025
pulisher
Sep 24, 2025

Vor Biopharma upgraded to Buy at Stifel on telitacicept prospects - Seeking Alpha

Sep 24, 2025
pulisher
Sep 24, 2025

Stifel upgrades Vor Biopharma stock to Buy on telitacicept prospects - Investing.com India

Sep 24, 2025
pulisher
Sep 24, 2025

Stifel Nicolaus Upgrades Vor Biopharma (NYSE:VOR) to Buy - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Vor Biopharma climbs after Stifel upgrades rating on autoimmune drug potential - TradingView

Sep 24, 2025
pulisher
Sep 23, 2025

Vor Biopharma (NYSE:VOR) Stock Price Down 8.6% Following Insider Selling - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Biopharma’s Strategic Moves and Telitacicept’s Potential Drive Buy Rating Amid Stock Decline - TipRanks

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Bio appoints Navid Khan as chief medical affairs officer By Investing.com - Investing.com South Africa

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Bio appoints Navid Khan as chief medical affairs officer - Investing.com

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Biopharma (VOR) Sees Significant Increase in Borrow Rate - GuruFocus

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Bio Appoints Navid Z. Khan, Ph.D., as Chief Medical Affairs Officer - GlobeNewswire

Sep 23, 2025
pulisher
Sep 23, 2025

7 Successful Drug Launches: Vor Bio Taps VYVGART Launch Veteran Navid Khan as Medical Affairs Chief - Stock Titan

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Biopharma (NASDAQ:VOR) Shares Down 7.2%What's Next? - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 22,363 Shares - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Analysts Set Vor Biopharma Inc. (NYSE:VOR) Price Target at $6.07 - MarketBeat

Sep 22, 2025
pulisher
Sep 21, 2025

Street Watch: Is Vor Biopharma Inc stock overvalued or fairly pricedTrade Entry Summary & Proven Capital Preservation Tips - خودرو بانک

Sep 21, 2025
pulisher
Sep 20, 2025

Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 447,278 Shares - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 20,000 Shares of Stock - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Momentum Shift: What is the PEG ratio of Vor Biopharma IncQuarterly Trade Report & Entry Point Confirmation Signals - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 14,240 Shares of Stock - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

Risk Report: Is Vor Biopharma Inc. part of any ETF2025 Price Action Summary & Verified Swing Trading Watchlists - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Reprogrammed Interchange Llc Sells 300,000 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Vor Biopharma Inc. recovery potential after sell offInflation Watch & Weekly Stock Performance Updates - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

How to interpret RSI for Vor Biopharma Inc. stockMarket Performance Summary & Verified Technical Signals - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Will Vor Biopharma Inc. rebound enough to break evenPortfolio Profit Report & Fast Moving Stock Watchlists - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Vor Biopharma ten percent owner sells $688k in shares By Investing.com - Investing.com Australia

Sep 19, 2025
pulisher
Sep 19, 2025

Vor Biopharma (VOR) Faces Trading Halt Amid Reverse Stock Split and Share Sale - GuruFocus

Sep 19, 2025
pulisher
Sep 19, 2025

Vor Biopharma trading halted on Thursday, news pending (VOR:NASDAQ) - Seeking Alpha

Sep 19, 2025
pulisher
Sep 19, 2025

Relative strength of Vor Biopharma Inc. in sector analysis2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com

Sep 19, 2025
pulisher
Sep 18, 2025

Will Vor Biopharma Inc. bounce back from current supportWeekly Investment Report & Weekly Watchlist for Hot Stocks - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

What momentum shifts mean for Vor Biopharma Inc.Market Activity Report & Reliable Entry Point Trade Alerts - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

What’s the recovery path for long term holders of Vor Biopharma Inc.July 2025 Pullbacks & Low Risk High Reward Ideas - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Vor Biopharma ten percent owner sells $688k in shares - Investing.com

Sep 18, 2025
pulisher
Sep 18, 2025

Using Bollinger Bands to evaluate Vor Biopharma Inc.Portfolio Gains Summary & Community Consensus Picks - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Gains Report: Is Vor Biopharma Inc stock overvalued or fairly pricedWeekly Trend Report & AI Driven Price Predictions - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Vor Biopharma Announces 1-for-20 Reverse Stock Split - TipRanks

Sep 18, 2025
pulisher
Sep 18, 2025

Vor Biopharma (NASDAQ:VOR) Rating Increased to Hold at Zacks Research - MarketBeat

Sep 18, 2025
pulisher
Sep 17, 2025

Vor Bio Announces Oral Presentation of 48-Week China Phase - GlobeNewswire

Sep 17, 2025
pulisher
Sep 17, 2025

Vor Biopharma announces 1-for-20 reverse stock split effective Thursday - Investing.com India

Sep 17, 2025
pulisher
Sep 17, 2025

Weekly Recap: How cyclical is Vor Biopharma Inc.’s revenue stream2025 Market Outlook & High Win Rate Trade Tips - khodrobank.com

Sep 17, 2025
pulisher
Sep 17, 2025

CEO Moves: Can Vor Biopharma Inc keep up with sector leadersJuly 2025 Highlights & Daily Market Momentum Tracking - خودرو بانک

Sep 17, 2025

보 바이오파마 (VOR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

보 바이오파마 주식 (VOR) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Reprogrammed Interchange LLC
10% Owner
Sep 15 '25
Sale
1.64
400,000
656,320
33,228,487
Reprogrammed Interchange LLC
10% Owner
Sep 12 '25
Sale
1.75
300,000
526,230
33,628,487
Reprogrammed Interchange LLC
10% Owner
Sep 11 '25
Sale
1.83
284,805
521,421
33,928,487
Reprogrammed Interchange LLC
10% Owner
Sep 08 '25
Sale
1.99
464,421
924,058
35,012,518
Reprogrammed Interchange LLC
10% Owner
Sep 09 '25
Sale
2.00
449,226
898,632
34,563,292
Reprogrammed Interchange LLC
10% Owner
Sep 10 '25
Sale
1.82
350,000
635,285
34,213,292
Reprogrammed Interchange LLC
10% Owner
Sep 03 '25
Sale
2.00
554,612
1,107,061
36,329,955
Reprogrammed Interchange LLC
10% Owner
Sep 04 '25
Sale
1.93
453,016
873,641
35,876,939
Reprogrammed Interchange LLC
10% Owner
Sep 05 '25
Sale
1.97
400,000
787,280
35,476,939
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
자본화:     |  볼륨(24시간):